Results 61 to 70 of about 1,844 (152)
Scientific ReportsRemimazolam, a novel intravenous anesthetic, has been proven to be safe and efficacious in the gastroscopy setting among the elderly. However, reports comparing the effectiveness and safety of using equivalent doses of remimazolam with propofol have not ...
Di Chen +4 more
doaj +1 more source
BMC AnesthesiologyObjective The objective of this study was to assess the efficacy and safety of Remimazolam in the context of combined spinal-epidural anesthesia for sedation during orthopedic surgery.
Yufei Chen +5 more
doaj +1 more source
Frontiers in OncologyBackgroundRemimazolam is a new ultrashort-acting benzodiazepine for sedation and anesthesia. The effects of remimazolam and the mechanism by which it functions in cancer cells have not been determined.
Runjia Wang +8 more
doaj +1 more source
Remimazolam: back to the future
Minerva AnestesiologicaRemimazolam can be considered a new anesthetic and sedative drug with broad prospects for use in various procedures across multiple clinical settings, including operating theaters, intensive care units, and non-operating room suites. It seems to have an excellent profile in terms of safety and efficacy for use by anesthesiologists, non-anesthesia ...
Romagnoli, Stefano +1 more
openaire +3 more sources
Perioperative MedicineAims Remimazolam is a novel, ultra-short-acting intravenous benzodiazepine. Its efficacy in reducing the occurrence of postoperative delirium (POD) and neurocognitive disorders remains unclear. Therefore, we conducted a meta-analysis to evaluate the long-
Dashuang Xi, Ming Yang, Hong Li
doaj +1 more source
Journal of Pharmacy and Bioallied SciencesBackground: “Postoperative nausea and vomiting (PONV)” are frequent adverse effects following anesthesia, which may exert significant implications on patient postoperative recovery and comfort.
Amiya K. Nayak +7 more
doaj +1 more source
Remimazolam use for awake craniotomy [PDF]
JA Clinical Reports, 2021 Shunsuke Tachibana +2 more
openaire +3 more sources
Remimazolam: a comprehensive review
Anaesthesiology Intensive TherapyRemimazolam is a novel, ultra-short-acting benzodiazepine that has emerged as a promising agent in modern anesthetic and intensive care practice. This review presents a detailed analysis of its pharmacokinetic and pharmacodynamic properties, clinical efficacy, and safety profile across various patient populations and procedural contexts.
Aleksander Aszkiełowicz +3 more
openaire +1 more source
Drug Design, Development and TherapyYuling Tang,1,2,* Menghong Long,1,2,* Yuhang Gao,1,2 Ana Kowark,3 Mark Coburn,3 Hengjun Wan,1,2 Yiyun Li,1,2 Xiaoxia Duan1 1Department of Anesthesiology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, People’s ...
Tang Y +7 more
doaj